Deregulated expression of Nucleophosmin 1 in gastric cancer and its clinicopathological implications

BMC Gastroenterology

Marília Cardoso Smith¹  Rommel Rodríguez Burbano⁵  Roger Chammas⁴  Paulo Pimentel Assumpção³  Samia Demachki³  Margarita Cortes Martinez⁴  Priscila Daniele Ramos Cirilo⁴  Danielle Queiroz Calcagno³  Tatiane Katsue Furuya Mazzotti⁴  Mariana Ferreira Leal² 

[1] Genetics Division, Department of Morphology and Genetic, Federal University of São Paulo, R. Botucatu, 740, São Paulo, SP CEP 04023-900, Brazil;Department of Orthopedics and Traumatology, Federal University of São Paulo, São Paulo, SP 04038-031, Brazil;Research Center of Oncology, João de Barros Barreto University Hospital, Federal University of Pará, Belém, PA 60673-000, Brazil;Center for Translational Oncology, São Paulo State Cancer Institute, São Paulo, SP 01246-000, Brazil;Human Cytogenetics Laboratory, Institute of Biological Sciences, Federal University of Pará, Belém, PA 66073-000, Brazil

关键词: Protein expression;    Gene expression;    Nucleophosmin;    Gastric cancer;   

Others  :  856715
DOI  :  10.1186/1471-230X-14-9

 received in 2013-03-05, accepted in 2013-12-31,  发布年份 2014

【 摘 要 】

Background

The process of gastric carcinogenesis still remains to be elucidated. The identification of genes related to this process may help to reduce mortality rates through early diagnosis and the development of new anticancer therapies. Nucleophosmin 1 (NPM1) acts in ribosome biogenesis, centrosome duplication, maintenance of genomic stability, and embryonic development. Recently, NPM1 has been implicated in the tumorigenesis processes. Here, we evaluated NPM1 gene and protein expression in gastric tumors and in corresponding non-neoplastic gastric samples.

Methods

NPM1 protein expression was determined by Western blot in 17 pairs of gastric tumors and corresponding non-neoplastic gastric tissue. The protein immunoreactivity was observed in 12 tumor samples. mRNA expression was evaluated by reverse transcription quantitative polymerase chain reaction (RT-qPCR) in 22 pairs of gastric tumors and in matched non-neoplastic gastric tissue.

Results

NPM1 protein expression was significantly reduced in gastric cancer samples compared to matched non-neoplastic gastric samples (P = 0.019). The protein level of NPM1 was reduced at least 1.5-fold in 35% of tumors compared to paired non-neoplastic gastric tissue. However, NPM1 immunoreactivity was detected in neoplastic and non-neoplastic cells, including in intestinal metaplastic, gastritis and inflammatory cells. NPM1 was mainly expressed in nucleus and nucleolus subcellular compartments. The staining intensity and the percentage of immunoreactive cells varied among the studied cases. The NPM1 mRNA level was reduced at least 1.5-fold in 45.5% of samples and increased in 27.3% of samples. An inverse correlation between protein and mRNA expression was detected (r = -0.509, P = 0.037). Intestinal-type gastric cancer presented higher mRNA levels than diffuse-type (P = 0.026). However, reduced NPM1 protein expression was associated with intestinal-type gastric cancer compared to matched non-neoplastic gastric samples (P = 0.018). In addition, tumors from patients with known distant metastasis presented reduced NPM1 protein levels compared to tumors from patients without distant metastasis (P < 0.001).

Conclusion

Although the expression of NPM1 is heterogeneous in gastric tumors, our results suggest that NPM1 down-regulation may have a role in gastric carcinogenesis and may help in the selection of anticancer treatment strategies.

【 授权许可】

   
2014 Leal et al.; licensee BioMed Central Ltd.

【 图 表 】

【 参考文献 】

• [1]Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin 2011, 61(2):69-90.
• [2]Leal MF, Chung J, Calcagno DQ, Assumpcao PP, Demachki S, da Silva ID, Chammas R, Burbano RR, de Arruda Cardoso Smith M: Differential proteomic analysis of noncardia gastric cancer from individuals of northern Brazil. PLoS One 2012, 7(7):e42255.
• [3]Grisendi S, Mecucci C, Falini B, Pandolfi PP: Nucleophosmin and cancer. Nat Rev Cancer 2006, 6(7):493-505.
• [4]Szebeni A, Olson MO: Nucleolar protein B23 has molecular chaperone activities. Protein Sci 1999, 8(4):905-912.
• [5]Okuwaki M, Tsujimoto M, Nagata K: The RNA binding activity of a ribosome biogenesis factor, nucleophosmin/B23, is modulated by phosphorylation with a cell cycle-dependent kinase and by association with its subtype. Mol Biol Cell 2002, 13(6):2016-2030.
• [6]Okuda M: The role of nucleophosmin in centrosome duplication. Oncogene 2002, 21(40):6170-6174.
• [7]Tarapore P, Okuda M, Fukasawa K: A mammalian in vitro centriole duplication system: evidence for involvement of CDK2/cyclin E and nucleophosmin/B23 in centrosome duplication. Cell Cycle 2002, 1(1):75-81.
• [8]Grisendi S, Bernardi R, Rossi M, Cheng K, Khandker L, Manova K, Pandolfi PP: Role of nucleophosmin in embryonic development and tumorigenesis. Nature 2005, 437(7055):147-153.
• [9]Gimenez M, Souza VC, Izumi C, Barbieri MR, Chammas R, Oba-Shinjo SM, Uno M, Marie SK, Rosa JC: Proteomic analysis of low- to high-grade astrocytomas reveals an alteration of the expression level of raf kinase inhibitor protein and nucleophosmin. Proteomics 2010, 10(15):2812-2821.
• [10]Nozawa Y, Van Belzen N, Van der Made AC, Dinjens WN, Bosman FT: Expression of nucleophosmin/B23 in normal and neoplastic colorectal mucosa. J Pathol 1996, 178(1):48-52.
• [11]Yun JP, Miao J, Chen GG, Tian QH, Zhang CQ, Xiang J, Fu J, Lai PB: Increased expression of nucleophosmin/B23 in hepatocellular carcinoma and correlation with clinicopathological parameters. Br J Cancer 2007, 96(3):477-484.
• [12]Tsui KH, Cheng AJ, Chang PL, Pan TL, Yung BY: Association of nucleophosmin/B23 mRNA expression with clinical outcome in patients with bladder carcinoma. Urology 2004, 64(4):839-844.
• [13]Skaar TC, Prasad SC, Sharareh S, Lippman ME, Brunner N, Clarke R: Two-dimensional gel electrophoresis analyses identify nucleophosmin as an estrogen regulated protein associated with acquired estrogen-independence in human breast cancer cells. J Steroid Biochem Mol Biol 1998, 67(5–6):391-402.
• [14]Shields LB, Gercel-Taylor C, Yashar CM, Wan TC, Katsanis WA, Spinnato JA, Taylor DD: Induction of immune responses to ovarian tumor antigens by multiparity. J Soc Gynecol Investig 1997, 4(6):298-304.
• [15]Subong EN, Shue MJ, Epstein JI, Briggman JV, Chan PK, Partin AW: Monoclonal antibody to prostate cancer nuclear matrix protein (PRO:4-216) recognizes nucleophosmin/B23. Prostate 1999, 39(4):298-304.
• [16]Qian Z, Joslin JM, Tennant TR, Reshmi SC, Young DJ, Stoddart A, Larson RA, Le Beau MM: Cytogenetic and genetic pathways in therapy-related acute myeloid leukemia. Chem Biol Interact 2010, 184(1–2):50-57.
• [17]Naoe T, Suzuki T, Kiyoi H, Urano T: Nucleophosmin: a versatile molecule associated with hematological malignancies. Cancer Sci 2006, 97(10):963-969.
• [18]Mendes-da-Silva P, Moreira A, Duro-da-Costa J, Matias D, Monteiro C: Frequent loss of heterozygosity on chromosome 5 in non-small cell lung carcinoma. Mol Pathol 2000, 53(4):184-187.
• [19]Falini B, Martelli MP, Bolli N, Sportoletti P, Liso A, Tiacci E, Haferlach T: Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity? Blood 2011, 117(4):1109-1120.
• [20]Zeller KI, Haggerty TJ, Barrett JF, Guo Q, Wonsey DR, Dang CV: Characterization of nucleophosmin (B23) as a Myc target by scanning chromatin immunoprecipitation. J Biol Chem 2001, 276(51):48285-48291.
• [21]Tanaka M, Sasaki H, Kino I, Sugimura T, Terada M: Genes preferentially expressed in embryo stomach are predominantly expressed in gastric cancer. Cancer Res 1992, 52(12):3372-3377.
• [22]You BJ, Huang IJ, Liu WH, Hung YB, Chang JH, Yung BY: Decrease in nucleophosmin/B23 mRNA and telomerase activity during indomethacin-induced apoptosis of gastric KATO-III cancer cells. Naunyn Schmiedebergs Arch Pharmacol 1999, 360(6):683-690.
• [23]Lauren P: The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. an attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965, 64:31-49.
• [24]Sobin LH, Gopodarowicz MK, Wittekind C: TNM Classification of Malignant Tumors. 7th edition. Oxford: Wiley-Blackwell; 2009.
• [25]Clayton CL, Kleanthous H, Coates PJ, Morgan DD, Tabaqchali S: Sensitive detection of Helicobacter pylori by using polymerase chain reaction. J Clin Microbiol 1992, 30(1):192-200.
• [26]Lobo Gatti L, Agostinho Jn F, De Labio R, Balbo Piason F, Carlos Da Silva L, Fagundez De Queiroz V, Peres CA, Barbieri D, De Arruda Cardoso Smith M, Marques Payao SL: Helicobacter pylori and cagA and vacA gene status in children from Brazil with chronic gastritis. Clin Exp Med 2003, 3(3):166-172.
• [27]Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001, 29(9):e45.
• [28]Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA, Grosveld G, Sherr CJ: Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 1997, 91(5):649-659.
• [29]Kuo ML, den Besten W, Bertwistle D, Roussel MF, Sherr CJ: N-terminal polyubiquitination and degradation of the Arf tumor suppressor. Genes Dev 2004, 18(15):1862-1874.
• [30]Karhemo PR, Rivinoja A, Lundin J, Hyvonen M, Chernenko A, Lammi J, Sihto H, Lundin M, Heikkila P, Joensuu H, et al.: An extensive tumor array analysis supports tumor suppressive role for nucleophosmin in breast cancer. Am J Pathol 2011, 179(2):1004-1014.
• [31]Liu Y, Zhang F, Zhang XF, Qi LS, Yang L, Guo H, Zhang N: Expression of nucleophosmin/NPM1 correlates with migration and invasiveness of colon cancer cells. J Biomed Sci 2012, 19:53. BioMed Central Full Text
• [32]Bonetti P, Davoli T, Sironi C, Amati B, Pelicci PG, Colombo E: Nucleophosmin and its AML-associated mutant regulate c-Myc turnover through Fbw7 gamma. J Cell Biol 2008, 182(1):19-26.
• [33]Calcagno DQ, Leal MF, Assumpcao PP, Smith MA, Burbano RR: MYC and gastric adenocarcinoma carcinogenesis. World J Gastroenterol 2008, 14(39):5962-5968.
• [34]Leal MF, Calcagno DQ, Khayat AS, Silva TC, Muniz JA, Assumpcao PP, de Arruda Cardoso Smith M, Burbano RR: hTERT and TP53 deregulation in intestinal-type gastric carcinogenesis in non-human primates. Clin Exp Med 2013, 13(3):221-224.
• [35]Assumpcao PP, Ishak G, Chen ES, Takeno SS, Leal MF, Guimaraes AC, Calcagno DQ, Khayat AS, Demachki S, Smith Mde A, et al.: Numerical aberrations of chromosome 8 detected by conventional cytogenetics and fluorescence in situ hybridization in individuals from northern Brazil with gastric adenocarcinoma. Cancer Genet Cytogenet 2006, 169(1):45-49.
• [36]Burbano RR, Assumpcao PP, Leal MF, Calcagno DQ, Guimaraes AC, Khayat AS, Takeno SS, Chen ES, De Arruda Cardoso SM: C-MYC locus amplification as metastasis predictor in intestinal-type gastric adenocarcinomas: CGH study in Brazil. Anticancer Res 2006, 26(4B):2909-2914.
• [37]Calcagno DQ, Guimaraes AC, Leal MF, Seabra AD, Khayat AS, Pontes TB, Assumpcao PP, De Arruda Cardoso SM, Burbano RR: MYC insertions in diffuse-type gastric adenocarcinoma. Anticancer Res 2009, 29(7):2479-2483.
• [38]Calcagno DQ, Leal MF, Demachki S, Araujo MT, Freitas FW, Oliveira e Souza D, Assumpcao PP, Ishak G, de Arruda Cardoso Smith M, Burbano RR: MYC in gastric carcinoma and intestinal metaplasia of young adults. Cancer Genet Cytogenet 2010, 202(1):63-66.
• [39]Calcagno DQ, Leal MF, Seabra AD, Khayat AS, Chen ES, Demachki S, Assumpcao PP, Faria MH, Rabenhorst SH, Ferreira MV, et al.: Interrelationship between chromosome 8 aneuploidy, C-MYC amplification and increased expression in individuals from northern Brazil with gastric adenocarcinoma. World J Gastroenterol 2006, 12(38):6207-6211.
• [40]Calcagno DQ, Leal MF, Taken SS, Assumpcao PP, Demachki S, Smith Mde A, Burbano RR: Aneuploidy of chromosome 8 and C-MYC amplification in individuals from northern Brazil with gastric adenocarcinoma. Anticancer Res 2005, 25(6B):4069-4074.
• [41]Costa Raiol LC, Figueira Silva EC, Mendes Da Fonseca D, Leal MF, Guimaraes AC, Calcagno DQ, Khayat AS, Assumpcao PP, De Arruda Cardoso Smith M, Burbano RR: Interrelationship between MYC gene numerical aberrations and protein expression in individuals from northern Brazil with early gastric adenocarcinoma. Cancer Genet Cytogenet 2008, 181(1):31-35.
• [42]Rosal-Texeira C, Leal MF, Calcagno DQ, Sozinho EKC, Borges BN, Montenegro RC, Santos AKR, Santos SEB, Ribeiro HF, Assumpção PP, et al.: MYC deregulation in gastric cancer and its clinicopathological implications. PLoS One 2013. in press
• [43]Lindstrom MS: NPM1/B23: a multifunctional chaperone in ribosome biogenesis and chromatin remodeling. Biochem Res Int 2011, 2011:195209.
• [44]Nawa Y, Kawahara K, Tancharoen S, Meng X, Sameshima H, Ito T, Masuda Y, Imaizumi H, Hashiguchi T, Maruyama I: Nucleophosmin may act as an alarmin: implications for severe sepsis. J Leukoc Biol 2009, 86(3):645-653.
• [45]Guery L, Benikhlef N, Gautier T, Paul C, Jego G, Dufour E, Jacquel A, Cally R, Manoury B, Vanden Berghe T, et al.: Fine-tuning nucleophosmin in macrophage differentiation and activation. Blood 2011, 118(17):4694-4704.
• [46]Enomoto T, Lindstrom MS, Jin A, Ke H, Zhang Y: Essential role of the B23/NPM core domain in regulating ARF binding and B23 stability. J Biol Chem 2006, 281(27):18463-18472.
• [47]Itahana K, Bhat KP, Jin A, Itahana Y, Hawke D, Kobayashi R, Zhang Y: Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation. Mol Cell 2003, 12(5):1151-1164.
• [48]Endo A, Matsumoto M, Inada T, Yamamoto A, Nakayama KI, Kitamura N, Komada M: Nucleolar structure and function are regulated by the deubiquitylating enzyme USP36. J Cell Sci 2009, 122(Pt 5):678-686.
• [49]Sato K, Hayami R, Wu W, Nishikawa T, Nishikawa H, Okuda Y, Ogata H, Fukuda M, Ohta T: Nucleophosmin/B23 is a candidate substrate for the BRCA1-BARD1 ubiquitin ligase. J Biol Chem 2004, 279(30):30919-30922.
• [50]Laurent JM, Vogel C, Kwon T, Craig SA, Boutz DR, Huse HK, Nozue K, Walia H, Whiteley M, Ronald PC, et al.: Protein abundances are more conserved than mRNA abundances across diverse taxa. Proteomics 2010, 10(23):4209-4212.
• [51]Lu P, Vogel C, Wang R, Yao X, Marcotte EM: Absolute protein expression profiling estimates the relative contributions of transcriptional and translational regulation. Nat Biotechnol 2007, 25(1):117-124.
• [52]Anderson L, Seilhamer J: A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 1997, 18(3–4):533-537.
• [53]de Sousa AR, Penalva LO, Marcotte EM, Vogel C: Global signatures of protein and mRNA expression levels. Mol Biosyst 2009, 5(12):1512-1526.
• [54]Raj A, Peskin CS, Tranchina D, Vargas DY, Tyagi S: Stochastic mRNA synthesis in mammalian cells. PLoS Biol 2006, 4(10):e309.
• [55]Tahara E: Genetic pathways of two types of gastric cancer. IARC Sci Publ 2004, 157:327-349.